IT Service Management (ITSM)
Design and launch service management practices — incident, problem, and change — to improve quality of IT services in regulated environments.
- ITSM
- Incident Management
- Problem Management
- Change Management
- Service Quality
Life Sciences Chief Information Officer — IT organization builder, business transformation, governance, and strategic planning in regulated environments.
Executive IT leader who has brought multiple products through FDA and commercialization. Leads M&A due diligence and integration, built a Cybersecurity program with Board approval, and improved IT–business alignment through IT Governance (ITGC) and Enterprise Architecture. Transformed business services to cloud and SaaS, redesigned IT SOPs for FDA and Sarbanes-Oxley (SOX) compliance, and specializes in building or transforming IT organizations with strategic plans, KPIs, and high-performing culture.
Peter has worked in life sciences for over 25 years across IT, digital marketing, business operations, and corporate strategy — from R&D and clinical operations through commercialization. Experience spans large multi-national pharma and biotech startups, including M&A due diligence, FDA-regulated product launches, and founding and scaling technology-driven companies.
Representative categories of projects and services delivered across pharmaceutical, biotech, and life sciences technology engagements:
Design and launch service management practices — incident, problem, and change — to improve quality of IT services in regulated environments.
Validated systems, SOPs, and audit-ready documentation for FDA-regulated R&D, clinical, QA, and manufacturing environments.
SOX readiness programs, IT general controls, and control frameworks aligned with Sarbanes-Oxley and internal audit requirements.
Enterprise-wide technology roadmaps for R&D, clinical operations, regulatory affairs, finance, and commercial launch readiness.
Security program development, employee training, and data integrity controls with board-level governance and executive sponsorship.
Capability roadmaps, business transformation methodology, and future-state architecture linking strategy to technology investments.
Technology due diligence, integration planning, and organizational alignment during mergers, acquisitions, and divestitures.
Launch-readiness roadmaps, non-personal promotion, SEO, paid search, field sales support, and multi-channel ROI analytics.
Organizational design, talent retention, outsourcing strategy, KPIs, and high-performing culture in startup and enterprise settings.
Pharmaceutical and biotech companies require IT that goes beyond infrastructure — understanding these nuances is critical to delivering value.
| Differentiator | IT Implication |
|---|---|
| Speed to Market | Act quickly while abiding by GxP regulations and validated system controls |
| Intellectual Property | Strong data governance, access controls, and user training to protect IP |
| Partnerships | Collaboration tools and policies for investors, CROs, and strategic partners |
| Dynamic Strategy | Agile resource shifting for M&A, commercial launches, and FDA audits |
| GxP Regulations | Validated systems, strong processes, and audit-ready documentation |
| SOX & ITGC | IT general controls, SOPs, and Sarbanes-Oxley readiness for public and pre-IPO companies |
Read the full framework in Life Sciences CIO: Making IT Not Suck.
AIthl33t
Boston, MA
Revalia Bio
New Haven, CT
Kadmon Pharmaceuticals
New York, USA
Kadmon Pharmaceuticals
New York, USA
Energize Technologies
New Jersey, USA
Daiichi Sankyo
New Jersey, USA
Daiichi Sankyo
New Jersey, USA
Daiichi Sankyo
New Jersey, USA
Daiichi Sankyo
New Jersey, USA
MBA, Strategy & Entrepreneurship
New York University, Stern School of Business
B.S. Information Technology (Honors)
Rochester Institute of Technology
PMP — Project Management Professional
Project Management Institute